A novel maxizyme vector targeting a bcr-abl fusion gene induced specific cell death in Philadelphia chromosome-positive acute lymphoblastic leukemia

Blood

Volumn 104, Issue 2, 2004, Pages 356-363

  Soda, Yasushi ^b   Tani, Kenzaburo ^a   Bai, Yuansong ^b   Saiki, Minoru ^b   Chen, Minghan ^b   Izawa, Kiyoko ^b   Kobayashi, Seiichiro ^b   Takahashi, Satoshi ^b   Uchimaru, Kaoru ^b   Kuwabara, Tomoko ^b   Warashina, Masaaki ^b   Tanabe, Tsuyoshi ^b   Miyoshi, Hiroyuki ^b   Sugita, Kanji ^b   Nakazawa, Shinpei ^b   Tojo, Arinobu ^b   Taira, Kazunari ^b   Asano, Shigetaka ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; CD34 ANTIGEN; HYBRID PROTEIN; LENTIVIRUS VECTOR; MAXIZYME; PROTEIN; PROTEIN P190; RIBOZYME; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOSTERISM; APOPTOSIS; ARTICLE; BCR ABL FUSION GENE; CELL DEATH; CELL VIABILITY; CHRONIC MYELOID LEUKEMIA; COLONY FORMATION; CONTROLLED STUDY; DNA VECTOR; E1A2MZ VECTOR; FUSION GENE; GENE; GENE INDUCTION; GENE TARGETING; GENE THERAPY; GENETIC TRANSDUCTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MAXIZYME VECTOR; PATHOGENESIS; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

EID: 3142592167     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-06-1948     Document Type: Article

References (37)

1. Faderl S, Talpaz M, Estrov Z, O'Brien S, Kurzrock R, Kantarjian HM. The biology of chronic myeloid leukemia. N Engl J Med. 1999;341:164-172.
2. Westbrook CA, Hooberman AL, Spino C, et al. Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762). Blood. 1992;80:2983-2990.
3. Copelan EA, McGuire EA. The biology and treatment of acute lymphoblastic leukemia in adults. Blood. 1995;85:1151-1168.
4. Arico M, Valsecchi MG, Camitta B, et al. Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. N Engl J Med. 2000;342:998-1006.
5. Druker BJ, Sawyers CL, Kaniarjian H, et al. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med. 2001; 344:1038-1042.
6. Ottmann OG, Druker BJ, Sawyers CL, et al. A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias. Blood. 2002;100:1965-1971.
7. Hofmann WK, Jones LC, Lemp NA, et al. Ph(+) acute lymphoblastic leukemia resistant to the tyrosine kinase inhibitor STI571 has a unique BCR-ABL gene mutation. Blood. 2002;99:1860-1862.
8. Branford S, Rudzki Z, Walsh S, et al. High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR/ ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance. Blood. 2002;99:3472-3475.
9. Uhlenbeck OC. A small catalytic oligoribonucleotide. Nature. 1987;328:596-600.
10. Haseloff J, Gerlach WL. Simple RNA enzymes with new and highly specific endoribonuclease activities. Nature. 1988;334:585-591.
11. Symons RH. Self-cleavage of RNA in the replication of small pathogens of plants and animals. Trends Biochem Sci. 1989;14:445-450.
12. Kuwabara T, Warashina M, Tanabe T, Tani K, Asano S, Taira K. A novel allosterically trans-activated ribozyme, the maxizyme, with exceptional specificity in vitro and in vivo. Mol Cell. 1998;2:617-627.
13. Kuwabara T, Warashina M, Orita M, Koseki S, Ohkawa J, Taira K. Formation of a catalytically active dimer by tRNA(Val)-driven short ribozymes. Nat Biotechnol. 1998;16:961-965.
14. Kuwabara T, Warashina M, Nakayama A, Ohkawa J, Taira K. tRNAVal-heterodimeric maxizymes with high potential as geneinactivating agents: simultaneous cleavage at two sites in HIV-1 Tat mRNA in cultured cells. Proc Natl Acad Sci USA. 1999;96:1886-1891.
15. Tanabe T, Kuwabara T, Warashina M, Tani K, Taira K, Asano S. Oncogene inactivation in a mouse model. Nature. 2000;406:473-474.
16. Tanabe T, Takata I, Kuwabara T, et al. Maxizymes, novel allosterically controllable ribozymes, can be designed to cleave various substrates. Biomacromolecules. 2000;1:108-117.
17. Stripecke R, Cardoso AA, Pepper KA, et al. Lentiviral vectors for efficient delivery of CD80 and granulocyte-macrophage-colony-stimulating factor in human acute lymphoblastic leukemia and acute myeloid leukemia cells to induce antileukemic immune responses. Blood. 2000;96:1317-1326.
18. Bal YS, Soda Y, Izawa K, et al. Effective transduction and stable transgene expression in human blood cells by a third-generation lentiviral vector. Gene Ther. 2003;10:1446-1457.
19. Ohyashiki K, Miyauchi J, Ohyashiki JH, et al. Interleukin-7 enhances colony growth and induces CD20 antigen of a Ph+ acute lymphoblastic leukemia cell line, OM9;22. Leukemia. 1993;7:1034-1040.
20. Inukai T, Sugita K, Mitsui K, et al. Participation of granulocyte colony-stimulating factor in the growth regulation of leukemia cells from Philadelphia chromosome-positive acute leukemia and blast crisis of chronic myeloid leukemia. Leukemia. 2000;14:1386-1395.
21. Lanotte M, Martin-Thouvenin V, Najman S, Balerini P, Valensi F, Berger R. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood. 1991;77:1080-1086.
22. Tsuji T, Waga I, Tezuka K, Kamada M, Yatsunami K, Kodama H. Integrin beta2 (CD18)-mediated cell proliferation of HEL cells on a hematopoietic- supportive bone marrow stromal cell line, H ESS-5 cells. Blood. 1998;91:1263-1271.
23. Koseki S, Tanabe T, Tani K, et al. Factors governing the activity in vivo of ribozymes transcribed by RNA polymerase III. J Virol. 1999;73:1868-1877.
24. Butler SL, Hansen MS, Bushman FD. A quantitative assay for HIV DNA integration in vivo. Nat Med. 2001;7:631-634.
25. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science. 2003;302:415-419.
26. Kustikova OS, Wahlers A, Kuhlcke K, et al. Dose finding with retroviral vectors: correlation of retroviral vector copy numbers in single cells with gene transfer efficiency in a cell population. Blood. 2003;102:3934-3937.
27. Kawaguchi Y, Jinnai I, Nagai K, et al. Effect of a selective Abl tyrosine kinase inhibitor, STI571; on in vitro growth of BCR-ABL-positive acute lymphoblastic leukemia cells. Leukemia. 2001;15:590-594.
28. Miyoshi H, Smith KA, Mosier DE, Verma IM, Torbett BE. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science. 1999;283:682-686.
29. Luther-Wyrsch A, Costello E, Thali M, et al. Stable transduction with lentiviral vectors and amplification of immature hematopoietic progenitors from cord blood of preterm human fetuses. Hum Gene Ther. 2001;12:377-389.
30. Mascarenhas L, Stripecke R, Case SS, Xu D, Weinberg KI, Kohn DB. Gene delivery to human B-precursor acute lymphoblastic leukemia cells. Blood. 1998;92:3537-3545.
31. Zennou V, Petit C, Guetard D, Nerhbass U, Montagnier L, Charneau P. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell. 2000;101:173-185.
32. Sirven A, Pflumio F, Zennou V, et al. The human immunodeficiency virus type-1 central DNA flap is a crucial determinant for lentiviral vector nuclear import and gene transduction of human hematopoietic stem cells. Blood. 2000;96:4103-4110.
33. Dardalhon V, Herpers B, Noraz N, et al. Lentivirus-mediated gene transfer in primary T cells is enhanced by a central DNA flap. Gene Ther. 2001;8:190-198.
34. Salmon P, Kindler V, Ducrey O, Chapuis B, Zubler RH, Trono D. High-level transgene expression in human hematopoietic progenitors and differentiated blood lineages after transduction with improved lentiviral vectors. Blood. 2000;96:3392-3398.
35. +ALL) during imatinib treatment. Leukemia. 2003;17:1700-1706.
36. Morizono K, Bristol G, Xie YM, Kung SK, Chen IS. Antibody-directed targeting of retroviral vectors via cell surface antigens. J Virol. 2001;75:80116-8020.
37. + ALL cells [abstract]. Blood. 2002;100:198a.